Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (OTCQB:OPNT)

7.97
Delayed Data
As of Mar 24
 +0.07 / +0.89%
Today’s Change
5.01
Today|||52-Week Range
10.51
+42.07%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Pollack Kevin A
Director
Buy1/13/20174,820$6.98$33.6K+17.73%
Sinclair Michael Jeffrey
Executive Chairman
Buy1/17/20173,500$7.00$24.5K+13.86%
Crystal Roger
Chief Executive Officer
Buy1/17/20173,475$6.99$24.3K+13.86%